Cyclopharm Limited announced a private placement of 100,000 common shares at an issue price of AUD 2.18 for the gross proceeds of AUD 218,000 on April 17, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 AUD | +1.17% | -3.89% | -10.13% |
03-19 | Cyclopharm's Technegas Device Carries Out Imaging of First US Patients | MT |
03-18 | Cyclopharm Limited(ASX:CYC) added to S&P/ASX All Ordinaries Index | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.13% | 111M | |
+8.88% | 219B | |
+8.68% | 185B | |
+14.25% | 135B | |
+28.18% | 107B | |
+14.65% | 51.28B | |
+4.48% | 51.01B | |
+4.39% | 41.85B | |
+7.00% | 37.02B | |
+26.06% | 31.27B |
- Stock Market
- Equities
- CYC Stock
- News Cyclopharm Limited
- Cyclopharm Limited announced that it expects to receive AUD 0.218 million in funding